DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction (FGR) and acute ischemic stroke ...

A new in silico design framework optimizes epi-ddRADseq enzyme pairs and size-selection windows across 75 plant species, ...

Single-molecule experiments reveal that one SauUSI restriction enzyme dimer from Staphylococcus aureus acts as an ATP-driven ...

Tailored immunoassay lines address common lab issues: low detectability, poor reproducibility, limited sample volume ...

In front of the squat rack at the gym, there is someone rubbing their knee.On the bar, there are the same weight plates as ...

An oral enzyme supplement appeared to reduce symptom severity for adults with irritable bowel syndrome (IBS), a prospective, ...

Lee Soo-man, Key Producer and Visionary Leader of A2O Entertainment (hereinafter A2O), who previously served as a producer at ...

It has been discovered that the chain length of lipids that make up cell membranes increases with age, a phenomenon common to ...

Anthropic's Claude discovered a novel enzyme system with properties reminiscent of CRISPR. Here is what it found and what remains unknown.

Sept 23 (Reuters) - Anthropic on Wednesday said its Claude model helped discover a novel enzyme system with properties reminiscent of mechanisms ‌in gene-editing technology CRISPR, marking the first ...

Anthropic introduced a new life sciences research group and laboratory on September 23, 2026 and shared early results in which, the company said, its Claude model autonomously discovered a previously ...